P2Y12 receptor antagonists (individualized therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P2Y12 receptor antagonists (individualized therapy), covering 2020-04-30 to 2020-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction [Phase 4]